Similar articles

• Acute hepatic failure associated with the use of sodium valproate.

  Suchy FJ, Balistreri WF, Buchino JJ, Sondheimer JM, Bates SR, Kearns GL, Stull JD, Bove KE. Suchy FJ, et al. N Engl J Med. 1979 Apr 26;300(17):962-6. doi: 10.1056/NEJM197904263001706. N Engl J Med. 1979. PMID: 372803 No abstract available.
• A suspected case of late-onset sodium-valproate-induced hepatic failure.

  van Egmond H, Degomme P, de Simpel H, Dierick AM, Roels H. van Egmond H, et al. Neuropediatrics. 1987 May;18(2):96-8. doi: 10.1055/s-2008-1052461. Neuropediatrics. 1987. PMID: 3110642
• Valproate hepatotoxicity: a review and report of two instances in adults.

  Dickinson RG, Bassett ML, Searle J, Tyrer JH, Eadie MJ. Dickinson RG, et al. Clin Exp Neurol. 1985;21:79-91. Clin Exp Neurol. 1985. PMID: 3939614
• [Valproate dosage].

  Meyer FP, Walther H. Meyer FP, et al. Psychiatr Neurol Med Psychol (Leipz). 1989 Mar;41(3):134-43. Psychiatr Neurol Med Psychol (Leipz). 1989. PMID: 2498918 Review. German.
• [Acute fatal liver insufficiency due to valproic acid therapy].

  Binek J, Hany A, Egloff B, Heer M. Binek J, et al. Schweiz Med Wochenschr. 1991 Feb 16;121(7):228-33. Schweiz Med Wochenschr. 1991. PMID: 2008603 Review. German.